AbbVie (ABBV) Capital Expenditures (2012 - 2026)
AbbVie (ABBV) reported Capital Expenditures of $322 million for Q2 2026, up 19.7% from $269 million a year earlier and up 21.5% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Capital Expenditures (2012 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, AbbVie's Capital Expenditures came in at $1.3 billion, up 24.2% year-over-year; for FY2025, it came in at $1.21 billion, up 24.6% from FY2024.
- Capital Expenditures has increased for three consecutive years, with a five-year compound annual growth rate of 8.8% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $974 million in FY2024 (+25.4%), $777 million in FY2023 (+11.8%), $695 million in FY2022 (-11.7%) and $787 million in FY2021 (-1.4%).
- Five-year quarterly Capital Expenditures spans a low of $143 million in Q2 2022 and a high of $381 million in Q3 2025.
- Year over year, Capital Expenditures has now increased in each of the last ten quarters, with growth averaging 23.4% over the last eight quarters.
- The high point for year-over-year Capital Expenditures in five years was Q3 2025 (growth of 53.0%); the low point was Q4 2021 (a decline of 33.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $265 million (Q1 2026), $329 million (Q4 2025) and $381 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Vertex Pharmaceuticals | 135.58 Bn | 107.59 Bn | 2.84 Bn | 112.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 322.00 Mn |
| Mar 31, 2026 | 265.00 Mn |
| Dec 31, 2025 | 329.00 Mn |
| Sep 30, 2025 | 381.00 Mn |
| Jun 30, 2025 | 269.00 Mn |
| Mar 31, 2025 | 235.00 Mn |
| Dec 31, 2024 | 291.00 Mn |
| Sep 30, 2024 | 249.00 Mn |
| Jun 30, 2024 | 241.00 Mn |
| Mar 31, 2024 | 193.00 Mn |
| Dec 31, 2023 | 205.00 Mn |
| Sep 30, 2023 | 219.00 Mn |
| Jun 30, 2023 | 178.00 Mn |
| Mar 31, 2023 | 175.00 Mn |
| Dec 31, 2022 | 213.00 Mn |
| Sep 30, 2022 | 177.00 Mn |
| Jun 30, 2022 | 143.00 Mn |
| Mar 31, 2022 | 162.00 Mn |
| Dec 31, 2021 | 187.00 Mn |
| Sep 30, 2021 | 217.00 Mn |
API Access
AbbVie Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();